Aurora, CO 的 肺高血壓 臨床試驗
9 項針對 肺高血壓 的研究正在 Aurora（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH)
招募中2 期
- University of Colorado Denver, Aurora
A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
招募中3 期
- University of Colorado Hospital, Aurora
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
招募中觀察性研究
- University of Colorado - Anschutz Medical Campus, Aurora
De-implementing Inhaled Nitric Oxide for Congenital Diaphragmatic Hernia
招募中4 期
- University of Colorado & Children's Hospital of Colorado (CU-CHC), Aurora
A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
招募中2 期
- University of Colorado, Aurora
Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH
招募中2 期
- Rocky Mountain Regional VA Medical Center, Aurora, CO, Aurora
Right Ventricular Response to Exercise Among Patients With Chronic Obstructive Pulmonary Disease
招募中
- University of Colorado Anschutz Medical Campus, Aurora
Phenotyping Resting and Exertional Right Ventricular Dysfunction Among Patients With Chronic Obstructive Pulmonary Disease
招募中
- University of Colorado Anschutz Medical Campus, Aurora
Pulmonary Hypertension Association Registry
招募中觀察性研究
- Children's Hospital Colorado, Aurora
- UC Health - Anschutz Medical Campus, Aurora
其他城市的 肺高血壓 試驗
- Philadelphia, PA10 項研究
- Phoenix, AZ9 項研究
- Cincinnati, OH8 項研究
- Indianapolis, IN8 項研究
- Boston, MA8 項研究
- New York City, NY8 項研究
- Kansas City, KS8 項研究
- Charleston, SC7 項研究
- Rochester, MN7 項研究
- Houston, TX7 項研究
- Salt Lake City, UT7 項研究
- Bend, OR7 項研究
Aurora 的其他研究
- 癌症（所有類型）35 項研究
- 大腸直腸癌32 項研究
- 非小細胞肺癌31 項研究
- 乳癌28 項研究
- 卵巢癌25 項研究
- 轉移性癌症25 項研究
- 第一型糖尿病23 項研究
- 肥胖症22 項研究
- 前列腺癌19 項研究
- 肺癌19 項研究
- 心臟衰竭18 項研究
- 黑色素瘤18 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。